Endovia Health Sciences (EDVA) Retained Earnings (2011 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Retained Earnings (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | -186.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -186.83 Mn |
| Mar 31, 2026 | -184.41 Mn |
| Dec 31, 2025 | -181.90 Mn |
| Sep 30, 2025 | 185.03 Mn |
| Jun 30, 2025 | 176.67 Mn |
| Mar 31, 2025 | -159.48 Mn |
| Dec 31, 2024 | -155.83 Mn |
| Sep 30, 2024 | -146.79 Mn |
| Jun 30, 2024 | -142.07 Mn |
| Mar 31, 2024 | -136.75 Mn |
| Dec 31, 2023 | -133.33 Mn |
| Sep 30, 2023 | -127.34 Mn |
| Jun 30, 2023 | 125.64 Mn |
| Mar 31, 2023 | 123.63 Mn |
| Dec 31, 2022 | 121.63 Mn |
| Sep 30, 2022 | 117.49 Mn |
| Jun 30, 2022 | 113.82 Mn |
| Mar 31, 2022 | 111.11 Mn |
| Dec 31, 2021 | 99.48 Mn |
| Sep 30, 2021 | 94.68 Mn |